Scientist- Director

We are looking for a Scientific Director to lead our efforts in variant classification in cancer susceptibility genes.  After detecting sequence variations in DNA, Myriad will classify these into 5 different categories for use in a clinical setting.  This program focuses on sequence variants (mutations) classified into categories which aren’t useful clinically, and strives to collect and analyze data to reclassify them to something clinically useful (polymorphism or deleterious/pathogenic).This Scientific Director will join our Medical Services team and help design and validate existing and novel methods of variant classification.  This “dry lab” scientific experience is unmatched in the clinical diagnostic industry and we are looking for someone passionate about the patient and willing to collaborate across disciplines to achieve high scientific standards.Backgrounds preferred include: molecular biology, genetics, genetic epidemiology, population genetics, biochemistry, bioinformatics and relevant experience and leadership is required.

• Design and validate novel methods of classification for genetic variants in cancer susceptibility genes
• Collaborate with in-house structural biologist to integrate Myriad’s emerging, industry-leading structural biology program into variant classification.
  • Collaborate with multiple disciplines to achieve robust scientific conclusions
  • Contribute to current methods of variant classification
  • Publish several manuscripts relevant to variant classification
  • Attend and present at relevant scientific meetings

PhD in related life science and relevant work experience. 5-10 years industry experience. Myriad Genetics, Inc. (Nasdaq: MYGN) is a leading molecular diagnostic company making a difference in patient’s lives through to discovery and commercialization of transformative molecular diagnostic products that assess a person’s risk of developing disease, improve diagnosis, predict disease progression and guide therapy. We believe in improving the healthcare management of patients by providing physicians and patients with critical information across multiple medical specialties that addresses unmet medical needs. With fiscal year 2013 annual revenue of approximately $600 million and more than 1,500 employees, Myriad is focusing on strategic initiatives, including growing our existing markets, launching new products, and expanding our global presence to take advantage of significant long-term growth opportunities. For more information on Myriad, please visit the Company’s website at: www.myriad.com. Myriad Genetics is an EEO/AAP employer and we do not discriminate on the basis of race, religion, national origin, sex, sexual orientation, age, physical or mental disability, marital status, or Veteran status. At Myriad, we affirm the right of every person to participate in all aspects of employment without regard to race, color, religion, sex, national origin, age, disability, or other protected classification. Myriad is an equal employment opportunity employer of individuals with disabilities and protected veterans. Reasonable accommodation will be provided for qualified individuals with disabilities and disabled veterans in job application procedures. We believe that diversity lends a regional, national, and global advantage to the clients we serve. Our workforce consists of dynamic individuals, with a range of backgrounds, talents, and skills.